+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Fertility Services Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 199 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016594
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Leaders seeking a competitive edge in the fertility services market must harness clear, actionable intelligence to drive strategic planning and operational excellence. This report provides critical insights for senior executives to navigate technology advances, shifting regulatory requirements, and evolving patient expectations.

Market Snapshot: Fertility Services Market Overview

The fertility services market stands at USD 47.55 billion in 2024 and is projected to reach USD 51.44 billion by 2025, reflecting robust momentum and an 8.31% CAGR through 2032. This growth trajectory is underpinned by rapid adoption of assisted reproductive technologies, expanded patient access, and notable demographic shifts, particularly later-age parenthood and increased fertility awareness. As the landscape matures, organizations are balancing innovation acceleration, patient-centered models, and adaptive compliance strategies to sustain leadership in a fragmented and regulated industry.

Scope & Market Segmentation

This comprehensive report empowers decision-makers to identify high-impact opportunities and streamline execution across the fertility services value chain. Core market segments and areas of focus include:

  • Procedure Types: Cryopreservation, Slow Freezing, Vitrification, In Vitro Fertilization (various methods), Intracytoplasmic Sperm Injection, Intrauterine Insemination, and Ovulation Induction. These options allow providers to build diverse offerings and foster differentiation for specialized patient needs.
  • End Users: Diagnostic Laboratories, Fertility Clinics, Hospitals, Surgical Centers. Each end user brings varying requirements for clinical workflows, infrastructure, and partnership models.
  • Infertility Categories: Combined Factor, Female Factor, Male Factor, Unexplained. Extensive category coverage supports multidisciplinary care pathways and increased patient personalization.
  • Payment Models: Government Insurance, Private Insurance, Employer Reimbursement, Self Funding. Flexible payment and reimbursement mechanisms are key to scaling access and supporting operational sustainability in the face of shifting payer trends.
  • Treatment Stages: Fresh Embryo Transfer, Elective Frozen Embryo Transfer, Medicated Frozen Embryo Transfer. Segmenting treatment stages enables optimized resource allocation and better clinical outcomes through tailored planning.
  • Age Demographics: Over Forty, Thirty-Five to Forty, Under Thirty-Five. Age-based segmentation ensures customized care delivery and sharpens demand forecasting for providers.
  • Regional Coverage: Americas, Europe, Middle East, Africa, Asia-Pacific. Each region presents unique policy regimes, technology adoption curves, and exposure to dynamic risks, reinforcing the importance of region-specific strategy.
  • Key Players Analyzed: IVI S.A., Progyny Inc., Monash IVF Group Limited, Eugin Group Holding S.L., Kindbody Inc., Inception Fertility LLC, CCRM Ltd., Shady Grove Fertility LLC, Boston IVF LLC, Extend Fertility LLC. This competitive benchmarking reveals evolving best practices and partnership opportunities across the market.

Key Takeaways: Strategic Insights for Decision Makers

  • Implementation of AI-driven embryo selection and remote patient monitoring streamlines clinic operations, enhances care accuracy, and expands access to advanced reproductive solutions.
  • Growing patient demand for personalized care and process transparency is leading providers to invest in digital engagement platforms and adaptable service delivery models.
  • Global regulatory complexity requires operational resilience and proactive clinical protocol management for cross-border service continuity and risk compliance.
  • Developing resilient and diversified supply chains helps organizations reduce exposure to disruptions arising from shifting policies, ensuring continuity in essential fertility procedures.
  • Collaboration between clinics, technology solutions providers, and regulators is fostering innovations that prioritize patient-centricity and facilitate expanded service delivery networks.
  • Customizing care pathways based on patient age and payer model increases inclusivity, improves cost-effectiveness, and maximizes long-term organizational value.

Tariff Impact on Supply Chain and Provider Strategy

In response to recent U.S. tariffs targeting fertility equipment and cryogenic technologies, providers are reevaluating procurement and capital strategies. Large fertility networks have greater ability to mitigate cost pressures due to scale, whereas smaller clinics face heightened exposure and must explore supplier renegotiation or new collaborations. Active engagement from industry bodies stresses the need for agile, well-diversified supply chains and emphasizes responsiveness to evolving policy landscapes to ensure uninterrupted equipment access across the fertility services market.

Methodology & Data Sources

This report synthesizes peer-reviewed research, regulatory analyses, and leading industry white papers. Expert interviews with senior executives and practicing clinicians validate the trends, while multidisciplinary panels safeguard the relevance of all findings.

Why This Report Matters: Fertility Services Market

  • Enables senior executives to anticipate market trends, shifting patient requirements, and policy developments, sharpening strategic risk management and growth planning.
  • Facilitates data-driven segmentation, with actionable regional and operational insights that inform resource optimization and service expansion.
  • Supports organizations in navigating supply chain vulnerabilities and partnership opportunities, ensuring continuity and organizational resilience in the fertility services sector.

Conclusion

Long-term success in fertility services will depend on aligning technology adoption, adaptive patient care models, and robust supply chain strategies. Decision-makers equipped with current, actionable intelligence are best positioned to create lasting organizational value and meet evolving market demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of AI-driven diagnostics to personalize fertility treatment protocols and improve success rates
5.2. Rising adoption of telehealth consultations for remote fertility assessments driving patient engagement
5.3. Expansion of fertility coverage by employers as part of comprehensive reproductive health benefits packages
5.4. Increasing investment in fertility clinics to expand advanced lab capabilities and improve research outcomes
5.5. Surge in elective egg freezing services fueled by career-oriented women seeking reproductive autonomy
5.6. Growth of genetic screening technologies in IVF cycles to reduce hereditary disease transmission risk
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Fertility Services Market, by Procedure Type
8.1. Cryopreservation
8.1.1. Slow Freezing
8.1.2. Vitrification
8.2. In Vitro Fertilization
8.2.1. Conventional IVF
8.2.2. Mini IVF
8.3. Intracytoplasmic Sperm Injection
8.4. Intrauterine Insemination
8.5. Ovulation Induction
9. Fertility Services Market, by End User
9.1. Diagnostic Laboratories
9.2. Fertility Clinics
9.3. Hospitals
9.4. Surgical Centers
10. Fertility Services Market, by Infertility Type
10.1. Combined Factor
10.2. Female Factor
10.3. Male Factor
10.4. Unexplained
11. Fertility Services Market, by Payment Type
11.1. Insurance Coverage
11.1.1. Government Insurance
11.1.2. Private Insurance
11.2. Out Of Pocket
11.2.1. Employer Reimbursement
11.2.2. Self Funding
12. Fertility Services Market, by Treatment Stage
12.1. Fresh Embryo Transfer
12.2. Frozen Embryo Transfer
12.2.1. Elective Frozen Embryo Transfer
12.2.2. Medicated Frozen Embryo Transfer
13. Fertility Services Market, by Age Group
13.1. Over Forty
13.2. Thirty Five To Forty
13.3. Under Thirty Five
14. Fertility Services Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Fertility Services Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Fertility Services Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. IVI S.A.
17.3.2. Progyny, Inc.
17.3.3. Monash IVF Group Limited
17.3.4. Eugin Group Holding S.L.
17.3.5. Kindbody, Inc.
17.3.6. Inception Fertility, LLC
17.3.7. CCRM Ltd.
17.3.8. Shady Grove Fertility, LLC
17.3.9. Boston IVF, LLC
17.3.10. Extend Fertility, LLC

Companies Mentioned

The companies profiled in this Fertility Services market report include:
  • IVI S.A.
  • Progyny, Inc.
  • Monash IVF Group Limited
  • Eugin Group Holding S.L.
  • Kindbody, Inc.
  • Inception Fertility, LLC
  • CCRM Ltd.
  • Shady Grove Fertility, LLC
  • Boston IVF, LLC
  • Extend Fertility, LLC

Table Information